Editas Medicine (EDIT) Operating Expenses (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Operating Expenses data on file, last reported at $32.1 million in Q3 2025.

• Operating Expenses for Q3 2025 came in at $32.1 million, down 51.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $168.0 million (down 40.72% YoY), and the FY2024 annual result was $283.5 million, up 14.62% from the prior year.
• Operating Expenses retreated to $32.1 million in Q3 2025 per EDIT's latest filing, from $55.1 million in the prior quarter.
• Over five years, Operating Expenses peaked at $84.0 million in Q4 2023 and troughed at $32.1 million in Q3 2025.
• A 5-year average of $61.2 million and a median of $60.6 million in 2022 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2024 and 2025: Operating Expenses jumped 54.14% in 2024, then sank 51.18% in 2025.
• A 5-year view of Operating Expenses shows it stood at $54.1 million in 2021, then increased by 29.41% to $70.0 million in 2022, then increased by 20.05% to $84.0 million in 2023, then retreated by 8.11% to $77.2 million in 2024, then tumbled by 58.43% to $32.1 million in 2025.
• Business Quant data shows EDIT's Operating Expenses at $32.1 million in Q3 2025, $55.1 million in Q2 2025, and $80.8 million in Q1 2025.